COVID-19 antibody testing: What coding and CDI professionals need to know

Why This Topic Matters

COVID-19 introduced frequent coding questions involving testing, history, symptoms, and concurrent conditions. Understanding the scope of this guidance helps coding and CDI professionals recognize when related documentation may affect diagnosis reporting and encounter sequencing.

Article Sections

1. Antibody testing and convalescent plasma therapy

   This section discusses the broader clinical context for serology testing and plasma therapy during the COVID-19 response. It also touches on public health considerations and testing-related controversy.

2. ICD-10-CM coding

   This section summarizes the article’s discussion of ICD-10-CM guidance related to COVID-19 antibody testing and related encounter types. It also references how the Coding Clinic Advisor FAQ frames several common reporting scenarios.

3. COVID-19 and two types of pneumonia

   This section addresses COVID-19 in relation to pneumonia-related reporting and the interaction of related diagnosis categories. It focuses on the presence of multiple conditions and official guideline considerations.

4. COVID-19 and HIV

   This section covers COVID-19 alongside HIV status and how the article describes sequencing considerations. It discusses the relationship between the conditions in general coding terms.

5. History of COVID-19

   This section reviews how the article discusses prior COVID-19 documentation, follow-up encounters, and history reporting. It explains the general role of personal history categories in this context.

6. COVID-19 signs and symptoms

   This section covers symptom reporting in COVID-19 cases, including respiratory and non-respiratory presentations. It also notes the article’s discussion of broader clinical manifestations and related research observations.